Dipeptidyl peptidase-4 (DPP-4) inhibitors, a class of antidiabetic drugs, have become standard drugs to improve hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus [27]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.